Replimune (REPL) Shares Outstanding (Weighted Average) (2017 - 2025)

Replimune has disclosed Shares Outstanding (Weighted Average) across 9 years of filings, most recently posting $91.9 million for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $91.9 million, up 10.03% year-over-year; the trailing twelve-month figure through Dec 2025 was $91.9 million (up 10.03% YoY), and the FY2025 annual result was $80.6 million, up 21.02% from the prior year.
• Shares Outstanding (Weighted Average) came in at $91.9 million for Q4 2025 at Replimune, roughly flat from $91.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $91.9 million in Q3 2025 to a low of $46.2 million in Q1 2021.
• The 5-year median for Shares Outstanding (Weighted Average) is $66.4 million (2023), against an average of $66.3 million.
• Across the five-year window, Shares Outstanding (Weighted Average) soared 34.99% in 2021 and grew 4.25% in 2024, its largest moves.
• Replimune's Shares Outstanding (Weighted Average) stood at $52.3 million in 2021, then climbed by 6.3% to $55.6 million in 2022, then rose by 19.62% to $66.5 million in 2023, then climbed by 25.5% to $83.5 million in 2024, then gained by 10.03% to $91.9 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $91.9 million (Q4 2025), $91.9 million (Q3 2025), and $91.5 million (Q2 2025), per Business Quant data.